title: Renal mesangium is a target for calcitonin gene-related peptide.
abstract: Rat calcitonin gene-related peptide (CGRP alpha; EC50, 1 nM) was shown to stimulate cAMP formation in cultured rat renal mesangial cells. CGRP concentration dependently (EC50, 1 nM) also inhibited contraction of mesangial cells by angiotensin II (10 nM). Angiotensin II (10 nM) caused a transient increase of the intracellular calcium concentration from 140 nM to 480 nM in the mesangial cells, but these calcium transients were not altered by CGRP. CGRP (10 nM) decreased vascular resistance in the isolated rat kidney perfused at constant pressure (100 mm Hg; P less than 0.01). The decreased vascular resistance was accompanied by a rise of the glomerular filtration fraction. CGRP, moreover, attenuated the effects of angiotensin II on renal vascular resistance and glomerular filtration (P less than 0.01). In conclusion, CGRP causes relaxation of renal mesangial cells and decreases renal vascular resistance. As a result CGRP raises glomerular filtration and the filtration fraction. The effect may be linked to cyclic AMP formation. Thus, regulation of renal vascular and glomerular function may represent a novel action of CGRP apart from its cardiovascular effects.
authors.affiliation: Physiologisches and Anatomisches Institut, Universität Zürich, Zürich, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Kurtz
authors.forename: H J
authors.initials: HJ
authors.lastname: Schurek
authors.forename: W
authors.initials: W
authors.lastname: Jelkmann
authors.forename: R
authors.initials: R
authors.lastname: Muff
authors.forename: H P
authors.initials: HP
authors.lastname: Lipp
authors.forename: U
authors.initials: U
authors.lastname: Heckmann
authors.forename: K U
authors.initials: KU
authors.lastname: Eckardt
authors.forename: H
authors.initials: H
authors.lastname: Scholz
authors.forename: J A
authors.initials: JA
authors.lastname: Fischer
authors.forename: C
authors.initials: C
authors.lastname: Bauer
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D002116:Calcitonin / Q000494:pharmacology*; D015740:Calcitonin Gene-Related Peptide; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005920:Glomerular Mesangium / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects / Q000502:physiology*; D007700:Kinetics; D008297:Male; D009479:Neuropeptides / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012079:Renal Circulation / Q000187:drug effects
chemical_list: D009479:Neuropeptides; D000804:Angiotensin II; D002116:Calcitonin; D000242:Cyclic AMP; D015740:Calcitonin Gene-Related Peptide